Search

Author/Creator Kantarjian, Hagop M

1. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Issue 10 (October 2020)

Authors:
DiNardo, Courtney D; Maiti, Abhishek; Rausch, Caitlin R; Pemmaraju, Naveen; Naqvi, Kiran; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Ohanian, Maro; Alvarado, Yesid; Issa, Ghayas C; Montalban-Bravo, Guillermo; Short, Nicholas J; Yilmaz, Musa; Bose, Prithviraj; Jabbour, Elias J; Takahashi, ...
Journal:
Lancet
Issue:
Volume 7:Issue 10(2020)
Page Start:
e724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial. Issue 4 (April 2020)

Authors:
Stein, Eytan M; Fathi, Amir T; DiNardo, Courtney D; Pollyea, Daniel A; Roboz, Gail J; Collins, Robert; Sekeres, Mikkael A; Stone, Richard M; Attar, Eyal C; Frattini, Mark G; Tosolini, Alessandra; Xu, Qiang; See, Wendy L; MacBeth, Kyle J; de Botton, Stéphane; Tallman, Martin S; Kantarjian, Hagop M
Journal:
Lancet
Issue:
Volume 7:Issue 4(2020)
Page Start:
e309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial. Issue 11 (November 2021)

Authors:
DiNardo, Courtney D; Schuh, Andre C; Stein, Eytan M; Montesinos, Pau; Wei, Andrew H; de Botton, Stéphane; Zeidan, Amer M; Fathi, Amir T; Kantarjian, Hagop M; Bennett, John M; Frattini, Mark G; Martin-Regueira, Patricia; Lersch, Frederik; Gong, Jing; Hasan, Maroof; Vyas, Paresh; Döhner, Hartmut
Journal:
Lancet oncology
Issue:
Volume 22:Issue 11(2021)
Page Start:
1597
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Issue 10 (October 2017)

Authors:
Kantarjian, Hagop M; Roboz, Gail J; Kropf, Patricia L; Yee, Karen W L; O'Connell, Casey L; Tibes, Raoul; Walsh, Katherine J; Podoltsev, Nikolai A; Griffiths, Elizabeth A; Jabbour, Elias; Garcia-Manero, Guillermo; Rizzieri, David; Stock, Wendy; Savona, Michael R; Rosenblat, Todd L; Berdeja, Jesus ...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 10(2017:Oct.)
Page Start:
1317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study. Issue 8 (August 2017)

Authors:
Kantarjian, Hagop M; DeAngelo, Daniel J; Advani, Anjali S; Stelljes, Matthias; Kebriaei, Partow; Cassaday, Ryan D; Merchant, Akil A; Fujishima, Naohito; Uchida, Toshiki; Calbacho, Maria; Ejduk, Anna A; O'Brien, Susan M; Jabbour, Elias J; Zhang, Hui; Sleight, Barbara J; Vandendries, Erik R; Marks,...
Journal:
Lancet
Issue:
Volume 4:Issue 8(2017)
Page Start:
e387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study. Issue 9 (September 2019)

Authors:
Ravandi, Farhad; Assi, Rita; Daver, Naval; Benton, Christopher B; Kadia, Tapan; Thompson, Philip A; Borthakur, Gautam; Alvarado, Yesid; Jabbour, Elias J; Konopleva, Marina; Takahashi, Koichi; Kornblau, Steven; DiNardo, Courtney D; Estrov, Zeev; Flores, Wilmer; Basu, Sreyashi; Allison, James; Shar...
Journal:
Lancet
Issue:
Volume 6:Issue 9(2019)
Page Start:
e480
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study. (1st April 2020)

Authors:
Bose, Prithviraj; McCue, David; Wurster, Sebastian; Wiederhold, Nathan P; Konopleva, Marina; Kadia, Tapan M; Borthakur, Gautam; Ravandi, Farhad; Masarova, Lucia; Takahashi, Koichi; Estrov, Zeev; Yilmaz, Musa; Daver, Naval; Pemmaraju, Naveen; Naqvi, Kiran; Rausch, Caitlin R; Marx, Kayleigh R; Qiao...
Journal:
Clinical infectious diseases
Issue:
Volume 72:Number 10(2021)
Page Start:
1755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗